Alan R. Boobis
About
Alan R. Boobis is a scholar working on Pharmacology, Cancer Research and Health, Toxicology and Mutagenesis.
According to data from OpenAlex, Alan R. Boobis has authored 364 papers receiving a total of 18.5k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Pharmacology, 86 papers in Cancer Research and 78 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Alan R. Boobis's work include Pharmacogenetics and Drug Metabolism (129 papers), Carcinogens and Genotoxicity Assessment (84 papers) and Effects and risks of endocrine disrupting chemicals (60 papers). Alan R. Boobis is often cited by papers focused on Pharmacogenetics and Drug Metabolism (129 papers), Carcinogens and Genotoxicity Assessment (84 papers) and Effects and risks of endocrine disrupting chemicals (60 papers). Alan R. Boobis collaborates with scholars based in United Kingdom, United States and Germany. Alan R. Boobis's co-authors include Donald S. Davies, D. S. Davies, Nigel J. Gooderham, Sandra Murray, Robert J. Edwards, Olavi Pelkonen, Robert J. Edwards, DS Davies, Suzanne E. Fenton and Alan Ducatman and has published in prestigious journals such as Science, Journal of Biological Chemistry and Environmental Science & Technology.
In The Last Decade
Alan R. Boobis
357 papers receiving 17.7k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Alan R. Boobis United Kingdom | 75 | 5.8k | 4.6k | 4.3k | 3.5k | 3.1k | 364 | 18.5k | ||
| Melvin E. Andersen United States | 73 | 2.4k 0.4× | 8.6k 1.9× | 4.9k 1.1× | 5.0k 1.4× | 790 0.3× | 467 | 20.7k | ||
| Nico Vermeulen Netherlands | 58 | 5.1k 0.9× | 4.7k 1.0× | 5.9k 1.4× | 1.2k 0.3× | 2.0k 0.6× | 469 | 19.2k | ||
| Ivonne M.C.M. Rietjens Netherlands | 67 | 2.3k 0.4× | 2.3k 0.5× | 5.9k 1.4× | 1.7k 0.5× | 1.2k 0.4× | 565 | 17.8k | ||
| Curtis D. Klaassen United States | 102 | 8.7k 1.5× | 10.9k 2.4× | 10.8k 2.5× | 2.2k 0.6× | 11.3k 3.6× | 829 | 40.2k | ||
| Martyn T. Smith United States | 79 | 932 0.2× | 6.2k 1.4× | 8.3k 1.9× | 5.4k 1.5× | 1.5k 0.5× | 366 | 22.9k | ||
| Franz Oesch Germany | 72 | 5.9k 1.0× | 2.2k 0.5× | 8.2k 1.9× | 4.5k 1.3× | 2.6k 0.8× | 576 | 19.6k | ||
| Allan H. Conney United States | 87 | 8.7k 1.5× | 3.1k 0.7× | 11.7k 2.7× | 6.2k 1.8× | 4.2k 1.4× | 373 | 29.2k | ||
| Olavi Pelkonen Finland | 61 | 6.4k 1.1× | 1.7k 0.4× | 3.9k 0.9× | 1.9k 0.6× | 2.8k 0.9× | 291 | 13.2k | ||
| Michael S. Denison United States | 61 | 1.5k 0.3× | 10.6k 2.3× | 3.9k 0.9× | 3.8k 1.1× | 1.0k 0.3× | 254 | 17.5k | ||
| Dieter Schrenk Germany | 47 | 1.3k 0.2× | 5.0k 1.1× | 2.8k 0.7× | 2.0k 0.6× | 1.6k 0.5× | 198 | 11.8k |
Countries citing papers authored by Alan R. Boobis
Since
Specialization
Citations
This map shows the geographic impact of Alan R. Boobis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan R. Boobis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan R. Boobis more than expected).
Fields of papers citing papers by Alan R. Boobis
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Alan R. Boobis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan R. Boobis. The network helps show where Alan R. Boobis may publish in the future.
Co-authorship network of co-authors of Alan R. Boobis
This figure shows the co-authorship network connecting the top 25 collaborators of Alan R. Boobis. A scholar is included among the top collaborators of Alan R. Boobis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan R. Boobis. Alan R. Boobis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Cohen, Samuel M., Alan R. Boobis, David Jacobson‐Kram, et al.. (2025). Mode of action approach supports a lack of carcinogenic potential of six organic UV filters. Critical Reviews in Toxicology. 55(2). 248–284.
2.
Firman, James W., Alan R. Boobis, Heli M. Hollnagel, et al.. (2024). Evaluating the consistency of judgments derived through both in silico and expert application of the Cramer classification scheme. Food and Chemical Toxicology. 194. 115070–115070.
3.
Boobis, Alan R., et al.. (2024). The new normal chemical landscape: the future of risk assessment toward optimum consumer safety. Toxicology Research. 13(2). tfae016–tfae016.
4.
Parish, Stanley T., Michael Aschner, Warren Casey, et al.. (2020). An evaluation framework for new approach methodologies (NAMs) for human health safety assessment. Regulatory Toxicology and Pharmacology. 112. 104592–104592.
5.
Autrup, Herman, Frank A. Barile, Colin Berry, et al.. (2020). Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?. Environmental Toxicology and Pharmacology. 78. 103396–103396.
6.
Cohen, Samuel M., Alan R. Boobis, Vicki L. Dellarco, et al.. (2019). Chemical carcinogenicity revisited 3: Risk assessment of carcinogenic potential based on the current state of knowledge of carcinogenesis in humans. Regulatory Toxicology and Pharmacology. 103. 100–105.
7.
Athersuch, Toby J., Daniel J. Antoine, Alan R. Boobis, et al.. (2018). Paracetamol metabolism, hepatotoxicity, biomarkers and therapeutic interventions: a perspective. Toxicology Research. 7(3). 347–357.
8.
Rotter, Stefanie, Anna Beronius, Alan R. Boobis, et al.. (2018). Overview on legislation and scientific approaches for risk assessment of combined exposure to multiple chemicals: the potential EuroMix contribution. Critical Reviews in Toxicology. 48(9). 796–814.
9.
Blaauboer, Bas J., Alan R. Boobis, Bobbie Bradford, et al.. (2016). Considering new methodologies in strategies for safety assessment of foods and food ingredients. Food and Chemical Toxicology. 91. 19–35.
10.
Zhu, Zheying, Robert J. Edwards, & Alan R. Boobis. (2009). Increased Expression of Histone Proteins during Estrogen-Mediated Cell Proliferation. Environmental Health Perspectives. 117(6). 928–934.
11.
Koh, Y.K.K., T.Y. Chiu, Alan R. Boobis, et al.. (2009). Fate and occurrence of alkylphenolic compounds in sewage sludges determined by liquid chromatography tandem mass spectrometry. Environmental Technology. 30(13). 1415–1424.
12.
Aboagye, Eric O., S. K. Luthra, F. Brady, et al.. (2002). Cancer Research UK procedures in manufacture and toxicology of radiotracers intended for Pre-phase I positron emission tomography studies in cancer patients. British Journal of Cancer. 86(7). 1052–1056.
13.
Jones, Hazel A., John B. Schofield, Thomas Krausz, Alan R. Boobis, & Christopher Haslett. (1998). Pulmonary Fibrosis Correlates with Duration of Tissue Neutrophil Activation. American Journal of Respiratory and Critical Care Medicine. 158(2). 620–628.
14.
Davies, D. S., et al.. (1992). Paracetamol toxicity and its prevention by cytoprotection with iloprost. Toxicology Letters. 64-65. 575–580.
15.
Jackson, Peter R., Alan R. Boobis, & Geoffrey T. Tucker. (1991). Phenotype or genotype. British Journal of Clinical Pharmacology. 31(1). 119–120.
16.
Edwards, Robert J., et al.. (1990). High affinity phenacetin O-deethylase is catalysed specifically by cytochrome P450d (P450IA2) in the liver of the rat. Biochemical Pharmacology. 39(3). 489–498.
17.
Murray, Stephen A., Nigel J. Gooderham, Alan R. Boobis, & D. S. Davies. (1988). An assay for 2-amino-3,8-dimethylimidazo[4,5-ƒ]-quinoxaline and 2-amino-3,4,8-trimethylimidazo-[4,5-ƒ]quinoxaline in fried beef using capillary column gas chromatography electron capture negative Ion chemical ionization mass spectrometry. Journal of Mass Spectrometry. 16(1-12). 221–224.
18.
Sesardic, Dorothea, Alan R. Boobis, Edward A. Lock, et al.. (1986). Inter-relatedness of some isoenzymes of cytochrome P-450 from rat, rabbit and human, determined with monoclonal antibodies. Biochemical Journal. 236(2). 569–577.
19.
Boobis, Alan R., et al.. (1985). Microsomes and drug oxidations : proceedings of the 6th International Symposium, Brighton, Sussex, United Kingdom, 5-10 August 1984. Taylor & Francis eBooks.
20.
Baillie, Thomas A., Alan R. Boobis, D. S. Davies, et al.. (1977). Studies on the metabolic fate of 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) in man [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 60(2). 280P–280P.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Melvin E. Andersen Breakdown of academic impact, for papers by Nico Vermeulen Breakdown of academic impact, for papers by Ivonne M.C.M. Rietjens Breakdown of academic impact, for papers by Curtis D. Klaassen Breakdown of academic impact, for papers by Martyn T. Smith Breakdown of academic impact, for papers by Franz Oesch Breakdown of academic impact, for papers by Allan H. Conney Breakdown of academic impact, for papers by Olavi Pelkonen Breakdown of academic impact, for papers by Michael S. Denison Breakdown of academic impact, for papers by Dieter Schrenk